News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
CALBIO15: Gene Therapy in "Second Honeymoon" Phase as Companies, Investors Swarm     3/2/2015
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics     3/2/2015
Shares Fall as the FDA Rejects Pacira (PCRX)'s Application for Expanded Use of Pain Drug     3/2/2015
Gilead (GILD)'s Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C and HIV     2/27/2015
Boehringer Ingelheim Puts Hold on Key Alzheimer's Drug Trial     2/27/2015
EXCLUSIVE: Science "Finally Catching Up" With GBM Tumors, Says DelMar Pharmaceuticals CEO     2/27/2015
Amgen (AMGN)'s Hormone-Imbalance Drug AMG 416 Shows Positive Results in Phase 3 Study     2/27/2015
Sanofi (SAN.PA) Wins FDA Approval for New Insulin Drug Toujeo     2/27/2015
EXCLUSIVE: DelMar Pharmaceuticals CEO Outlines 2015 Plans, Looks to Clinical Cancer Trials     2/27/2015
TherapeuticsMD, Inc.  (TXMD) Has "Multiple Catalysts" in 2015/16 As Products Develop, Says Cowen and Company     2/26/2015
Pfizer (PFE)'s Meningitis B Vaccine Meets Safety, Tolerability Goals in Mid-Stage Study     2/25/2015
Genentech (RHHBY)'s Breast Cancer Cocktail Buys More Than a Year of Life     2/25/2015
Novartis AG (NVS)'s Farydak Wins FDA Approval After Setback     2/25/2015
Celldex (CLDX)'s Rindopepimut Deemed a Breakthrough By the FDA     2/24/2015
Rigel (RIGL) Lands $339 Million+ Cancer Deal With Bristol-Myers Squibb (BMY)     2/24/2015

News from Around the Web
Treadmill Performance Predicts Risk Of Death, Johns Hopkins University Study     3/2/2015
How Pollution May Make You Obese, University of Granada Study     3/2/2015
Your Brain Knows Your Next Move Before You Do, Howard Hughes Medical Institute Study     3/2/2015
Shake It Off? Not So Easy For People With Depression, University of Michigan Medical School Study     3/2/2015
Gilead (GILD) Holds Cash Overseas to Save Billions on Taxes     2/27/2015
Decision On Ebola Mass Vaccination In August At Earliest: WHO     2/27/2015
Twin Study Lends New Insights Into Link between Back Pain And Depression, University of Sydney Reveals     2/27/2015
First World War Explosive Could Reverse Diabetes, Yale University Study     2/27/2015
Chinese Herb Effective In Treating Ebola, Texas Biomedical Research Institute Study Reveals     2/27/2015
Can Coffee Cut Your MS Risk? Johns Hopkins University Study     2/27/2015
Elite Athletes's DNA May Hold The Secret To A Healthy Heart, Stanford University Study     2/27/2015
Widely Used Food Additive In Processed Foods Linked To Weight Gain, Inflammation, Georgia State University Research Shows     2/27/2015
Links Between Omega-3s And Vitamin D Explored, Children's Hospital Oakland Research Institute Study     2/27/2015
Chronic Insomnia Linked To Higher Risk Of Death, University of Arizona Study     2/27/2015
Sleeping Over Eight Hours A Day Could Raise Stroke Risk, University of Cambridge Reveals     2/27/2015

Press Releases
Actavis (ACT) Hormonal Contraceptive Device Wins FDA Approval     3/2/2015
Pacira Pharmaceuticals, Inc. (PCRX) Receives Complete Response Letter From FDA For sNDA Seeking Approval Of EXPAREL Use In Nerve Block To Provide Postsurgical Analgesia     3/2/2015
Shire (SHPGY) Submits Application To The U.S. D&A Pharma For Approval Of Lifitegrast For Treatment Of Dry Eye Disease In Adults     3/2/2015
European Medicines Agency Accepts Santen, Inc.'s Marketing Application Filing For Intravitreal Sirolimus For The Treatment Of Noninfectious Uveitis Of The Posterior Segment     3/2/2015
Celgene International Sárl (CELG) Release: ABRAXANE Approved By European Commission For First-Line Treatment Of Patients With Non-Small Cell Lung Cancer     3/2/2015
Newron Pharmaceuticals (NWRN) Release: Xadago (Safinamide) New Drug Application (NDA) Accepted For Filing By The FDA     3/2/2015
Amgen (AMGN) Release: Phase 3 Head-To-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis (Carfilzomib) Over Velcade (Bortezomib) In Patients With Relapsed Multiple Myeloma     3/2/2015
Otsuka Pharmaceutical Co., Ltd. Release: First-Ever Treatment Approved In Canada For Adults Living With ADPKD, A Life-Threatening Kidney Disease     3/2/2015
Portola Pharmaceuticals, Inc. Announces Full Results From Positive Phase 3 ANNEXA-R Study Demonstrating That Andexanet Alfa Rapidly And Significantly Reversed Anticoagulant Effect Of Factor Xa Inhibitor XARELTO     3/2/2015
Transition Therapeutics Inc. (TTH.TO) Announces Enrolment Completion Of ELND005 Phase 2 Clinical Study In Agitation And Aggression In Patients With Alzheimer's Disease     3/2/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Cancer Of The Fallopian Tube     3/2/2015
Acasti Pharma Receives Full Data For Phase II TRIFECTA Trial     3/2/2015
Aldeyra Therapeutics (ALDX) Provides Update On NS2 Clinical Program     3/2/2015
Opsona Therapeutics Ltd. Commences Part B Of Phase II Study Of Blocking Toll-Like Receptor 2 In Extended Criteria Donor Renal Transplant Recipients At High Risk Of Early Graft Dysfunction     3/2/2015
Almac Discovery Initiates Phase 1 Study Of ALM201 For The Treatment Of Patients With Advanced Ovarian Cancer And Other Solid Tumours     3/2/2015

//-->